The investigational compounds; novel phthalazine derivatives for cancer targeting vegfr kinase inhibitors
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: KIM, Chae Won (Duksung Women's University, College of Pharmacy, Seoul, Korea, Republic Of)
- Co-author(s): Chae Won Kim: College of Pharmacy, Duksung Women's University, Seoul, Korea, Republic Of
Myung-Sook Park: College of Pharmacy, Duksung Women's University, Seoul, Korea, Republic Of
"EN-US">According to the reported data of National Cancer Information Center in 2015, South Koreans have been troubled with cancer since 1999, amounting to a total of approximately 1.46 million. Therefore, for a long time, many global pharmaceutical companies have been trying to develop cancer drugs. Vatalanib, which received FDA.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.